PBH (STOCKS)
Prestige Consumer Healthcare Inc.
$46.670000
-1.150000 (-2.40%)
Prev close: $47.820000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Ronald M. Lombardi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,211.81M
- Employees
- 600
- P/E (TTM)
- 12.24
- P/B (TTM)
- 1.20
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
4
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q4)
|
$1.23 | $1.40 | -0.1739 | -12.39% |
|
Dec 2025 (Q3)
|
$1.14 | $1.16 | -0.0157 | -1.36% |
|
Sep 2025 (Q2)
|
$1.07 | $0.98 | +0.0900 | +9.18% |
|
Jun 2025 (Q1)
|
$0.95 | $1.01 | -0.0602 | -5.96% |
Financial Statements
| Revenues | $1.09B |
| Benefits Costs and Expenses | $831.21M |
| Cost Of Revenue | $493.13M |
| Costs And Expenses | $831.21M |
| Gross Profit | $595.58M |
| Operating Expenses | $286.17M |
| Operating Income/Loss | $309.41M |
| Income/Loss From Continuing Operations After Tax | $190.30M |
| Income/Loss From Continuing Operations Before Tax | $257.50M |
| Income Tax Expense/Benefit | $67.20M |
| Income Tax Expense/Benefit, Deferred | $22.70M |
| Interest Income/Expense After Provision For Losses | -$52.67M |
| Interest Income/Expense Operating, Net | -$42.34M |
| Net Income/Loss | $190.30M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $190.30M |
| Net Income/Loss Available To Common Stockholders, Basic | $190.30M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $10.33M |
| Basic Earnings Per Share | $3.93 |
| Diluted Earnings Per Share | $3.91 |
| Basic Average Shares | 48,456,000 |
| Diluted Average Shares | 48,720,000 |
| Assets | $3.49B |
| Current Assets | $431.48M |
| Inventory | $159.13M |
| Other Current Assets | $272.35M |
| Noncurrent Assets | $3.06B |
| Fixed Assets | $121.69M |
| Intangible Assets | $2.30B |
| Other Non-current Assets | $641.54M |
| Liabilities | $1.61B |
| Current Liabilities | $120.92M |
| Accounts Payable | $22.79M |
| Interest Payable | $15.58M |
| Wages | $12.13M |
| Other Current Liabilities | $70.43M |
| Noncurrent Liabilities | $1.49B |
| Long-term Debt | $993.95M |
| Other Non-current Liabilities | $491.92M |
| Equity | $1.89B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.89B |
| Liabilities And Equity | $3.49B |
| Net Cash Flow From Operating Activities | $257.63M |
| Net Cash Flow From Operating Activities, Continuing | $257.63M |
| Net Cash Flow From Investing Activities | -$136.84M |
| Net Cash Flow From Investing Activities, Continuing | -$136.84M |
| Net Cash Flow From Financing Activities | -$156.06M |
| Net Cash Flow From Financing Activities, Continuing | -$156.06M |
| Exchange Gains/Losses | $1.26M |
| Net Cash Flow | -$34.02M |
| Net Cash Flow, Continuing | -$35.28M |
| Comprehensive Income/Loss | $199.59M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $199.59M |
| Other Comprehensive Income/Loss | $199.59M |
| Other Comprehensive Income/Loss Attributable To Parent | $9.29M |